By Mark DeCambre and Victor Reklaitis, MarketWatch
The IBB is on track for its worst daily drop since the U.K.'s
vote to exit from the European Union
U.S. stocks were on a record run in Wednesday afternoon
trade.
The Dow industrials, S&P 500 and small-cap focused Russell
2000 on Wednesday all rose to all-time highs in intraday trade as
stocks extended early gains and shook off early weakness in the
health-care sector.
The Dow Jones Industrial Average set an all-time trading high of
19,343.62 and most recently was trading up 85 points, or 0.4%, at
19,337, on track for its third consecutive record close. Gains in
American Express Co. (AXP), Home Depot Inc.(HD) and United
Technologies Corp..(UTX) outweighed a slump in health-care shares
of Johnson & Johnson(JNJ)Pfizer Inc.(PFE), and Merck & Co.
Inc.(MRK).
Health-care names tumbled early Wednesday after President-elect
Donald Trump threatened to cut drug prices
(http://www.marketwatch.com/story/president-elect-trumps-promise-to-bring-down-drug-prices-sends-biotech-etfs-slumping-2016-12-07).
"I'm going to bring down drug prices," Trump told Time in his
"Person of the Year" cover story
(http://time.com/time-person-of-the-year-2016-donald-trump/). "I
don't like what has happened with drug prices."
The iShares Nasdaq Biotechnology ETF(IBB), the most widely used
way to place bets on the biotech space, sank 4.5%, and was on track
for its worst daily decline since after the U.K. vote to abandon
its membership with the European Union roiled markets in late June,
according to FactSet data.
However, the broader market traded firmly higher later in the
session, shaking off those early concerns, in midafternoon trade
ahead of key meetings of European and U.S. central banks, which
could influence investor sentiment.
The Nasdaq Composite Index which had been trading in negative
territory, turned higher to trade up 6 points, or 0.1%, at
5,339.
The S&P 500 index set an intraday trading high of 2,219.32,
exceeding its intraday high set Nov. 30, and was most recently up
less than 0.3%, at 2,219, with all but the health-care sector, off
1.6%, in the green.
Meanwhile, the Russell 2000 index , a gauge of the shares of
small-capitalization companies touched an intraday trading record
of 1,357.15. The index has climbed 13.4% since the U.S.
presidential election.
The stock market's postelection climb has been underpinned by
hopes that Trump will follow through with a slate of pro-business
policies, including boosting infrastructure spending and cutting
taxes for the wealthy.
Frank Cappelleri, executive director at Instinet LLC, said
investors caught flat-footed by the sustained rally following
Trump's unexpected Election Day win are still rotating into
stocks.
"Investors may see a few days of a pause as a reason to get back
involved," said Cappelleri. He said the second reason why this move
can extend higher is because investors betting on a downturn "are a
little gun shy" after getting burned in November.
Other strategist say the market has traded in a relatively
narrow range since 2014 and make the case that for that reason the
recent monthlong Trump rally has a shot at moving higher into the
end of the year.
"It has only been about four weeks since the breakout for stocks
and a lot of people are looking at this to be quickly aborted, but
the market shouldn't be faulted for expecting more," said Bruce
Bittles, chief investment strategist at brokerage firm Robert W.
Baird & Co., a brokerage.
Another factor that may be supporting stock gains is traditional
selling patterns that occur at the end of the year aren't being
followed because investors are making bets on lower taxes under a
Trump administration. "Anyone who has gained [in December] are not
going to want to sell their stocks and pay taxes in April 2017,
when they can wait till 2018," he said. Of course taxes on profits
from the sale of assets could be higher then, but Bittles says Wall
Street traders are betting that it makes more sense to wait and
see, which is reducing traditional selling of stocks to take
year-end profits and encouraging buying.
"It appears that nothing can stop the equity rally," said Naeem
Aslam, chief market analyst at ThinkMarkets UK, in a note.
However, some strategists and traders are concerned that a
pullback
(http://www.marketwatch.com/story/gundlach-says-the-trump-trade-is-losing-steam-2016-12-02)
might be in the offing because the market has climbed too fast and
too furiously.
However, the CBOE Volatility Index trading at around 11, implies
that investors may be getting complacent. "Buying volatility at
these levels may not be that much of a bad idea," Aslam said.
Read:Why the rally by U.S. stocks is 'just getting started'--in
one chart
(http://www.marketwatch.com/story/why-the-rally-by-us-stocks-is-just-getting-started-in-one-chart-2016-11-28)
Other markets:European stocks
(http://www.marketwatch.com/story/credit-suisse-miners-push-stoxx-europe-600-toward-highest-close-since-september-2016-12-07)
finished higher, with banks and miners among the session's big
winners, and Asian markets closed broadly higher
(http://www.marketwatch.com/story/bank-stocks-surge-as-asian-markets-post-gains-2016-12-06).
Oil futures
(http://www.marketwatch.com/story/oil-prices-continue-to-backtrack-as-investors-question-opec-deal-2016-12-07)
retreated, while gold futures and a key dollar index
(http://www.marketwatch.com/story/dollar-flattens-out-as-investors-look-ahead-to-fed-ecb-meetings-2016-12-07)
were modestly higher.
Individual stocks: Ahead of the opening bell, Brown-Forman
Corp.(BFA) reported quarterly sales that topped estimates
(http://www.marketwatch.com/story/brown-forman-sales-top-estimates-sticks-with-full-year-view-2016-12-07),
as the maker of Jack Daniel's whiskey backed its full-year
forecast. The stock wasn't yet active in premarket trade.
Handbag seller Vera Bradley Inc.(VRA) cut its full-year outlook
(http://www.marketwatch.com/story/vera-bradley-shares-slump-as-company-cuts-outlook-2016-12-07)
after missing its own guidance range for the third quarter. Shares
were tumbling 7% in early trade.
Economic news: A report on consumer credit is due at 3 p.m.
Eastern.
The JOLTS report, or Job Openings and Labor Turnover Survey,
showed that job openings were unchanged at 5.5 million in October,
according to Labor Department.
Investors also are bracing for the European Central Bank's
policy-setting meeting
(http://www.marketwatch.com/story/how-italys-no-vote-might-be-the-ecbs-silver-lining-2016-12-05)
on Thursday. The Federal Reserve entered the so-called blackout
period Tuesday ahead of its meeting Dec. 13-14, so there are no Fed
speakers on the docket.
Check out:
(END) Dow Jones Newswires
December 07, 2016 12:40 ET (17:40 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
iShares Biotechnology ETF (NASDAQ:IBB)
Historical Stock Chart
From Sep 2024 to Oct 2024
iShares Biotechnology ETF (NASDAQ:IBB)
Historical Stock Chart
From Oct 2023 to Oct 2024